CRISIL Limited
Corporate Identity Number: L67120MH1987PLC042363
Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400076. Phone: +91 22 3342 3000 | Fax: +91 22 3342 3001 www.crisil.com
April 19, 2023
Listing Department
National Stock Exchange of India Ltd.
Exchange Plaza, 5th floor Plot No. C/1, G Block Bandra-Kurla Complex Bandra (East)
Mumbai 400 051
Listing Department BSE Limited P J Towers Dalal Street Mumbai 400 001
Dear Sirs
Sub.: CRISIL Limited – Unaudited Financial Results published On April 19, 2023 in Financial Express and Sakal
Kindly be informed that the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended March 31, 2023 have been published today i.e. on April 19, 2023 in newspapers, Financial Express and Sakal.
A print layout copy of the same is enclosed.
Kindly inform your members accordingly.
Yours faithfully, For CRISIL Limited
Minal Bhosale Company Secretary ACS 12999
Encl.:
CRISIL
An S&P Global Company
MINAL AMIT BHOSALE
Digitally signed by MINAL AMIT BHOSALE Date: 2023.04.19 13:33:32 +05'30'
19
FINANCIAL EXPRESS
WWW.FINANCIALEXPRESS.COM WEDNESDAY, APRIL 19, 2023
Call for Proposal
�
Financial Assistance to Feasibility Study Projects, R&D Projects and Pilot Projects.
�
Funding shall be in the form of Grants/ Conditional Grants.
�
Funding upto 70% for start-ups less than 5 years-old.
(Whichever is lower)
�
Indian company registered under the Indian Company Act 1956/2013 as Indian Project Lead (INPL).
�
At least 51% stake of the INPL Company must be owned by Indian citizens.
�
Sole proprietors and partnership firms are not eligible for support under this programme.
For finding partner/ match making support, drop a mail at [email protected], For more Details, Funding Guidelines & Proposal Submission visit- www.tdb.gov.in
CBC 36106/12/0005/2324Technology Development Board
Department of Science & Technology
Technology Bhawan, Block-2, 2nd Floor, New Delhi
India - Israel
Industrial R&D and Technological Innovation Fund (I4F) 2023 CFP-10
Key Features
Eligibility
(Formerly known as AVENTIS PHARMA LIMITED) Registered Office: SanofiHouse, CTS No. 117- B, L & T Business Park, Saki Vihar Road, Powai, Mumbai - 400072
SANOFI INDIA LIMITED
LOST AND FOUND
NOTICE is hereby given that the certificate for the under mentioned shares of the Company has been lost & the holders of the said certificate have applied to the Company for issue of duplicate share certificate..
Any person who has any claim in respect of the said certificate should lodge such claim with the Company at its Registered Office within 15 days from the date of publication of this Notice. In the absence of any claim, the Company shall proceed to issue duplicate certificate without further intimation.
Folio No. Name of the Shareholders Cert. Nos. Dist. Nos. Shares 00097491 DEEPAK TALWAR
DEEPA TALWAR 83894
83895 83896 83897 83898 83899
21974233-21974282 21974283-21974332 21974333-21974382 21974383-21974432 21974433-21974482 2-1974483-21974532
5050 5050 5050 SANOFI INDIA LIMITED - GIRISH TEKCHANDANI (COMPANY SECRETARY) Place: : Mumbai
Date : 18.04.2023
�������� ��������� �������� �������
��������� ������ � ����� ������ ������� ��� ������ ���� ������ ����
�������� ����� ����� ���� ������� ����������� � ������
������ ������
���� �� �� ������ ��� ������ ����������� �� ������� ���� ��������� ���� �� ���������
�� �������� ��������� �������� ������� ������� ��� ����������� ������� ������� ����
���� ���� ����� ������������ �� ����� ���� ���� ���
���� ��������� ����� ������ ������ ������� ����������� ����������� ����
��������� �� �� ��������� ������ �� ���� �������� �� ��� ������� ��������� ���
���� ������ �� ��� ����� ���� ��� ������� �� ������� ���� ���� ���� ������ �� �����
���������� ��� ���� ��������� �� �� ��������� ������ �� ������� ������������ ��
��� ������� ��������� ��������� ����� ��������������
������� �������������������� � ����������� ����������
��� ������������������������� ������� �������������������������
������ ���� ���� ������
�������������
��������� ��� ����� �� ����� ��� ������ �� �������� �� �� ��������� � � �������� �
������ ��� ������� ������� ��� ����� �������
�������������
CRISIL LIMITED CR I SIL
Rogd. Office: CRISIL Houso. Central Avenue,
Hiranandani Business Park, Powai, Mumbai• 400076. CIN: l67120MH1987PLC042363 An S&P Global Company
Tel.: 022·33423000; Fax: 022·33423001; Website: www.cnsll.com; E-mail: [email protected]
EXTRACT OF FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31 , 2023
{f In Crore)
SI. Particulars Consolidated Standalone
No 3 Month$ 3 l'l'lonths Corresponding Veer
•
3 Months 3 Months Coffespondlng YMilended ended 3 Mor-.hs eocled ended ended
ended
3Monhended encled31..vtar~23 31-Del>22 31-Mar-22 3 1 ~ 31.f.w-23 31-000.22. 31-Mar-22 31-Dec,.22.
( R ~ Refer note 5)
Unaudited
Auclted
UnauditedAudited
Unaudited Audi1ed Unaudited Audited (Refer n0le 3)(Re4er
note 3) (Re(etnote3) (Rei!, note 3)(Re(et
note 3) (Refer nole 3)1 Revenue from operations 714.89 822.26 594.94 2,768.72 375.13 389.23 324.71 1,444.12 2 Net Profi1 for the penod
before tax 193.63 207.00 169,31 742.40 132.01 128.12 110,54 441.86
3 Net Profl1 for the period
atter tax 145.75 158.02 121.62 564.39 109.71 109.80 88.03 370.51
4 Total Comprehensive Income for the pe1iod [Composing Profit for the penod (after tax) and Other Comprehenwe
Income (after tax)) 166.55 223.02 88.24 521.17 125.95 126.26 58.38 348.20
5 Equity Share Capital 7.31 7.31 7.30 7.31 7.31 7.31 7.30 7.31
6 Other equity 1,784.67 1,063.07
7 Earnings Per Share (of f 1/· each)
1. Basic ; (Not annualised) 19.95 21.63 16,68 77.31 15.01 15.03 12.07 50.75 2. OIIU1ed: (Not annualised) 19.94 21.62 16.66 n.26 15.01 15.02 12.06 50.72 Notes:
1. The above results have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at rls meeting held on April 18, 2023,
2. The hnanclal results have been prepared in accordance with the applicable accounting standards, as notified under the Companies {Indian Accountmg Standards) Rules, 2015 and as specified in Section 133 of the Companies Act.
3. In compliance wrth Regulation 33 of the Securities and E~change Soard of India (Usling Obligations and Disclosure Requirements) Regulallons, 2015, a limited review of the results has been carried out by the Statutory Auditors of the Company. The figures of the quarter ended O~mber 31, 2022 are lhe balancing ligures between audited figures of the full year ended Deoember 31, 2022 and unaudited published year lo date figures 1.1p to th-e penod ended September 30, 2022.
4. The above Is an extract of the detalled format of quarter ended Financial Resui1s filed with the S1ock Exel\anges. The lull format of the quarter ended Financial Results are available on www.crisll.com and also on the websites ol BSE Limited (www.bseindia.com) and National Stock Excnange or India Limited (www.nse,ndia.com).
5. The Board of Directors has approved arrangement for amalgamation ol two wholly owned subs1d1aries ("CRISIL Risk and lnfrastrucwre Solutlons Limited (CRIS) and Pragmati~ Services Private llmlled (PSPL) • Transferor Company·] wlih the Company (the "Transferee Company") In Us meeting held on December 13, 2021. The $(heme has been sanctioned by ltte National Company
Law
Tribunal (NCLT) with appomled date as Apnl 1, 2022. The Scheme became effective on September 1, 2022. On fihng of approved scheme with AOC. the Company has accounted for lhe merger using the Pooling ol interest method as prescribed In Ind AS 103 -"Business Comblna1tons". The figures of corresponding quarter ended Match 31. 2022 In 1tte standalone ,esutts hawe been accordingly restaled.
r.in
For and on behalf of the Board of Directors of CRISIL Limited Amish Mehta Managing Director and Chler E>recuhve Officer DlN : 00046254